Accepted at 2:58 p.m. Oct, 31, 2023 by dollajas
Author: Gustav
Related Note: 1472673197430
Rationale for change

Not sure if it is high yield enough but ezetimibe's effect on the NPC1L1 protein has at least appeared quite a few times at my medical school. Source: https://doi.org/10.2147%2FVHRM.S33664
"One such agent is ezetimibe, a cholesterol absorption inhibitor that targets uptake at the jejunal enterocyte brush border. Its primary target of action is the cholesterol transport protein Nieman Pick C1 like 1 protein. "

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Cholestyramine & Ezetimibe
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Watch Ezetimibe

Physeo


Bootcamp
Watch associated Bootcamp video - Lipid Metabolism : Hyperlipidemia Pharmacology
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#OME::PreClinical::Cardiac #AK_Step1_v12::#UWorld::COMLEX::25589 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::02_Dyslipidemia_Drugs::02_Cholestyramine_&_Ezetimibe #AK_Step1_v12::#UWorld::Step::11634 #AK_Step1_v12::#AMBOSS::P6aWOl #AK_Step1_v12::#Bootcamp::Biochemistry::09_Lipid_Metabolism::09_Hyperlipidemia_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::11_Ezetimibe #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::10_Lipid-lowering_Agents::Ezetimibe #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::16_Ezetimibe #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#B&B::03_Biochem::05_Lipids::03_Lipid_Drugs #AK_Step1_v12::#UWorld::Step::164 #PANCE::CARDIO::lipid_disorders #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::11_Ezetimibe #AK_Step1_v12::#UWorld::COMLEX::23277 !AK_UpdateTags::Step1decks::Zanki-Pharmacology